Saturday, August 1, 2026

Chungha’s Upcoming EP Alivio Reveals Inner Struggles with Bold New Track ‘STRESS’

Chungha teases her upcoming EP "Alivio" with a bold "STRESS" music video, exploring themes of inner turmoil and liberation.

Against All ODDS: Trump’s Unscheduled Gamble at the DMZ Could Finally End the North Korean Nuclear Crisis

Trump acknowledges North Korea's nuclear power status and is open to meeting Kim Jong Un during his Asian tour.

Dongkoo Bio&Pharma Invests 1 Billion KRW in GenomAndCompany: What This Means for ADC Drug Development

Dongkoo Bio&Pharma invests 1 billion KRW in Genome & Company to enhance antibody and ADC drug development strategies.

Health

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.
Latest

Kolon Group’s Biotech Bet Faces Uncertainty as October Trial Readout Becomes Critical

Kolon TissueGene's TG-C osteoarthritis treatment failed its first U.S. Phase 3 trial, raising doubts about the biotech's future.

Revolutionary SperoQure: How JNPMEDI is Transforming Osteoarthritis Treatment in 2026

JNPMEDI will support clinical trials for speroQure, a novel cell therapy for osteoarthritis, ensuring a smooth and effective process.

Unlocking the Brain’s Secrets: New Discovery of CSF Drainage Holes Could Revolutionize Alzheimer’s Treatment

A South Korean team discovered openings in the arachnoid membrane that allow cerebrospinal fluid to drain, crucial for brain health.

How ACM Treatment Reduces Suicide Risk in Severe Depression: A 6-Month Study

A study shows intensive management by mental health professionals can significantly reduce suicide risk in severely depressed patients.

Foreign Health Insurance Enrollment Surges 28%: What This Means for Asia’s Healthcare Landscape

Foreign health insurance in the U.S. surged 28% to 1.68 million subscribers, showing a surplus of 2.8 trillion KRW over three years.

Novo Nordisk vs Eli Lilly: Is Weight Loss Advertising Misleading?

Novo Nordisk sues Eli Lilly for misleading ads on obesity drugs, claiming false comparisons and seeking corrective action in court.

Hugel Launches Letybo in India: What This Means for the Aesthetic Market in 2026

Hugel enters the Indian market with its botulinum toxin product Letybo, targeting a 9% share in the aesthetic sector this year.

Lunit Joins Global AI Consortium for Next-Gen Drug Development: What This Means for Precision Medicine

Lunit joins an AI consortium to enhance drug development through AI-driven pathology and biomarker analysis, collaborating with global firms.

Celltrion Group’s 2 Trillion KRW Investment: What It Means for Global Bio Manufacturing by 2032

Celltrion Group plans a 2 trillion KRW investment to enhance production capacity and establish a leading position in global biotech.

Celltrion Expands PFS Production Capacity to 70 Million: What This Means for the Global Market

Celltrion Pharmaceutical plans to invest 2 trillion KRW to expand its pre-filled syringe production capacity to meet global demand.

Regenerative Medicine Expanded to Four Diseases Including Knee Osteoarthritis; Medipost and CHA Biotech Seen as Potential Beneficiaries

The Korean government is easing regulations on regenerative medicine, boosting biotech, and enabling patient access to validated therapies.

From Preclinical Development to Licensing: JNPMEDI Aims to Accelerate K-Biotech Growth With AI

JNPMEDI emphasizes the need for Korea's biotech sector to enhance global commercialization and reduce clinical trial costs using AI.

NGeneBio Expands Blood Cancer Diagnostic Panel Supply to Seoul National University Bundang Hospital

NGeneBio expands its blood cancer diagnostic panel supply, achieving strong growth in South Korea and international markets.

AI Model Enables Detection of Breathing Abnormalities During Surgery Without Blood Draws

South Korean researchers developed an AI model for noninvasive monitoring of pediatric patients' arterial carbon dioxide during surgery.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.